All In Biotech

Free tool

FAERS Monitor: Atoncy

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 220320 or its brand name (Atoncy, Atomoxetine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

2,613

Serious

2,294

88% of reports

Hospitalization

1,386

Death reported

1,293

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use786
  • drug ineffective670
  • epilepsy620
  • pain618
  • confusional state613
  • hypoaesthesia609
  • maternal exposure during pregnancy608
  • psoriatic arthropathy598
  • swelling590
  • rheumatoid arthritis589
  • abdominal pain upper588
  • systemic lupus erythematosus578
  • type 2 diabetes mellitus577
  • pericarditis572
  • condition aggravated571

Reports by year received

View as table
YearReports
200411
200527
20069
200725
20102
20116
201219
201317
201422
201539
201618
201721
201846
201958
202048
202175
2022147
2023197
2024445
2025928
2026453

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,546 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pericarditisSignal572283.7263.4155,500
epilepsySignal620166.6155.499,965
type 2 diabetes mellitusSignal577140.3130.578,452
systemic lupus erythematosusSignal578133.2123.974,619
psoriatic arthropathySignal598120.3112.169,752
maternal exposure during pregnancySignal60855.351.532,268
swellingSignal59051.147.528,853
rheumatoid arthritisSignal58942.039.123,522
hypoaesthesiaSignal60932.930.718,850
confusional stateSignal61330.628.617,621
abdominal pain upperSignal58823.121.512,468
condition aggravatedSignal57115.114.17,625
painSignal6188.17.63,954
off label useSignal7867.26.84,393
drug ineffectiveSignal6704.13.81,667

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.